Louise Frederika Kooij insider trades

Open-market stock purchases and sales by Louise Frederika Kooij, Chief Accounting Officer at NewAmsterdam Pharma Co NV, from SEC Form 4 filings since Jan 1, 2024.

Recent trades

DateStockTradeValue
Jun 22, 2026NAMS NewAmsterdam Pharma Co NVSold$1.2M
Jun 22, 2026NAMS NewAmsterdam Pharma Co NVSold$9.2K
Jun 22, 2026NAMS NewAmsterdam Pharma Co NVBought (not open market)—
Jun 22, 2026NAMS NewAmsterdam Pharma Co NVBought (not open market)—
May 26, 2026NAMS NewAmsterdam Pharma Co NVSold$2.3M
May 26, 2026NAMS NewAmsterdam Pharma Co NVBought (not open market)—
May 26, 2026NAMS NewAmsterdam Pharma Co NVBought (not open market)—
Jan 28, 2026NAMS NewAmsterdam Pharma Co NVSold$1M
Jan 28, 2026NAMS NewAmsterdam Pharma Co NVBought (not open market)—
Jan 27, 2026NAMS NewAmsterdam Pharma Co NVSold$1.3M
Jan 27, 2026NAMS NewAmsterdam Pharma Co NVBought (not open market)—
Jan 26, 2026NAMS NewAmsterdam Pharma Co NVSold$1.1M
Jan 26, 2026NAMS NewAmsterdam Pharma Co NVSold$10.3K
Jan 26, 2026NAMS NewAmsterdam Pharma Co NVBought (not open market)—
Jan 23, 2026NAMS NewAmsterdam Pharma Co NVSold$850K
Jan 23, 2026NAMS NewAmsterdam Pharma Co NVSold$439K
Jan 23, 2026NAMS NewAmsterdam Pharma Co NVBought (not open market)—
Jan 7, 2026NAMS NewAmsterdam Pharma Co NVBought (not open market)—
Jan 7, 2026NAMS NewAmsterdam Pharma Co NVBought (not open market)—
Jan 5, 2026NAMS NewAmsterdam Pharma Co NVSold$88K
Dec 26, 2025NAMS NewAmsterdam Pharma Co NVBought (not open market)—
Dec 26, 2025NAMS NewAmsterdam Pharma Co NVBought (not open market)—
Dec 26, 2025NAMS NewAmsterdam Pharma Co NVSold$1.5M
Dec 24, 2025NAMS NewAmsterdam Pharma Co NVSold$928K
Dec 24, 2025NAMS NewAmsterdam Pharma Co NVBought (not open market)—

Companies traded

  • NAMS NewAmsterdam Pharma Co NV: 19 sales, last Jun 22, 2026

Get free alerts when Louise Frederika Kooij files a new trade →